REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Tecnandina S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Tecnandina S.A. Profile Updated: April 07, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Tecnandina S.A. is based in Ecuador. The head office is in Pomasqui. It operates in the Pharmaceutical and Medicine Manufacturing industry. Tecnandina S.A. was incorporated on April 29, 1975. 254 (2024) employees currently work for Tecnandina S.A.. In its most recent financial highlights, the company reported a net sales revenue increase of 35.27% in 2025. A growth of 4.66% was recorded in its total assets. The net profit margin of Tecnandina S.A. increased by 2.07% in 2025.

Headquarters
Calle El Paraiso
Pomasqui; Pichincha;

Contact Details: Purchase the Tecnandina S.A. report to view the information.

Website: http://www.tecnandina.com

Basic Information
Total Employees:
Purchase the Tecnandina S.A. report to view the information.
Registered Capital:
Purchase the Tecnandina S.A. report to view the information.
Financial Auditors:
Purchase the Tecnandina S.A. report to view the information.
Incorporation Date:
April 29, 1975
Key Executives
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
97.44%
Purchase this report to view the information.
2.56%
Company Performance
Financial values in the chart are available after Tecnandina S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
35.27%▲
Total Operating Revenue
31.83%▲
Operating Profit
72.7%▲
EBITDA
70.77%▲
Net Profit/Loss for the Period
100.76%▲
Total Assets
4.66%▲
Total Equity
6.86%▲
Operating Profit Margin
2.43%▲
Net Profit Margin
2.07%▲
Return on Equity (ROE)
3.25%▲
Debt / Equity
0.3%▲
Quick Ratio
0.19%▲
Cash Ratio
-0.19%▼

Similar companies

Quifatex S.A.
 
Laboratorios Siegfried S.A.
Roche Ecuador S.A.
 
Bayer S.A.
Nefrocontrol S.A.
 
Novartis Ecuador S.A.
Acromax Laboratorio Quimico Farmaceutico S.A.
 
James Brown Pharma C.A.
Opella Healthcare Ecuador S.A.S.
 
Indeurec S.A.
Merck Sharp & Dohme LLC
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo